---
figid: PMC9593054__fphar-13-998574-g003
figtitle: NLRP3-mediated pyroptosis in diabetic nephropathy
organisms:
- Oryza sativa
- Candida dubliniensis
- Ophiocordyceps sinensis
- Hibiscus sabdariffa
- Abelmoschus manihot
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Hepatitis B virus
- Shigella flexneri
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Danio rerio
pmcid: PMC9593054
filename: fphar-13-998574-g003.jpg
figlink: /pmc/articles/PMC9593054/figure/F3/
number: F3
caption: TXNIP/NLRP3 signaling pathway is involved in the regulation of pyroptosis.
  (1) TXNIP can inhibit the antioxidant activity of Trx. (2) The deficiency of TXNIP
  can inhibit the MAPK/NF-κB signaling pathway and mTOR/NF-κB signaling pathway. (3)
  IRE1α/miR-200a/TXNIP signaling pathway, ANRIL/miR-497/TXNIP signaling pathway, mROS/TXNIP
  signaling pathway and EZH2/EGR1/TXNIP/NLRP3 signaling pathway, they all can regulate
  the activation of TXNIP. (4) Nrf2 can inhibit the expression of TXNIP, and FOXO1
  can promote the expression of TXNIP. (5) The interaction of TXNIP with NLRP3 can
  promote the activation of NLRP3 inflammasome and lead to increased expression of
  cleaved-caspase-1 and GSDMD-N.
papertitle: NLRP3-mediated pyroptosis in diabetic nephropathy.
reftext: Jiayi Wan, et al. Front Pharmacol. 2022;13:998574.
year: '2022'
doi: 10.3389/fphar.2022.998574
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: diabetic nephropathy | pyroptosis | pathogenesis | signaling pathways |
  drugs
automl_pathway: 0.9162406
figid_alias: PMC9593054__F3
figtype: Figure
redirect_from: /figures/PMC9593054__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9593054__fphar-13-998574-g003.html
  '@type': Dataset
  description: TXNIP/NLRP3 signaling pathway is involved in the regulation of pyroptosis.
    (1) TXNIP can inhibit the antioxidant activity of Trx. (2) The deficiency of TXNIP
    can inhibit the MAPK/NF-κB signaling pathway and mTOR/NF-κB signaling pathway.
    (3) IRE1α/miR-200a/TXNIP signaling pathway, ANRIL/miR-497/TXNIP signaling pathway,
    mROS/TXNIP signaling pathway and EZH2/EGR1/TXNIP/NLRP3 signaling pathway, they
    all can regulate the activation of TXNIP. (4) Nrf2 can inhibit the expression
    of TXNIP, and FOXO1 can promote the expression of TXNIP. (5) The interaction of
    TXNIP with NLRP3 can promote the activation of NLRP3 inflammasome and lead to
    increased expression of cleaved-caspase-1 and GSDMD-N.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nfkb1
  - Ezh2
  - Nfe2l2
  - Egr1
  - Tgfb1
  - Ltbp1
  - Foxo1
  - Mtor
  - ap
  - Apk
  - Txnip
  - Ern1
  - Mir200a
  - Mir497
  - Vac14
  - Nlrp3
  - Pycard
  - Gm12610
  - Gsdmd
  - Th
  - NFKB1
  - EZH2
  - GABPA
  - NFE2L2
  - EGR1
  - TGFB1
  - TGFB2
  - TGFB3
  - FOXO1
  - MTOR
  - TXNIP
  - ERN1
  - MIR200A
  - MIR497
  - TXN
  - VAC14
  - NLRP3
  - STS
  - PYCARD
  - CDKN2B-AS1
  - GSDMD
  - ezh2
  - nfe2l2a
  - egr1
  - foxo1a
  - mtor
  - txnipa
  - mir200a
  - nlrp3
  - pycard
---
